Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma

INTRODUCTION: Perioperative therapy is standard for patients with borderline-resectable pancreatic ductal adenocarcinoma (BR-PDAC); however, an optimal neoadjuvant regimen is lacking. We assessed the efficacy of FOLFIRINOX chemotherapy followed by gemcitabine-based chemoradiation as preoperative the...

Descripción completa

Detalles Bibliográficos
Autores principales: Acuna-Villaorduna, Ana, Shankar, Viswanathan, Wysota, Michael, Jirgal, Amanda, Kabarriti, Rafi, Bellemare, Sarah, Goldman, Inessa, Kaubisch, Andreas, Aparo, Santiago, Goel, Sanjay, Chuy, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558866/
https://www.ncbi.nlm.nih.gov/pubmed/36221952
http://dx.doi.org/10.1177/10732748221134411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558866/
https://www.ncbi.nlm.nih.gov/pubmed/36221952
http://dx.doi.org/10.1177/10732748221134411

Ejemplares similares